Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA.
Carcinogenesis. 2015 Jan;36(1):49-59. doi: 10.1093/carcin/bgu213. Epub 2014 Oct 20.
Inflammation, hormones and energy-related factors have been associated with colorectal cancer (CRC) and it has been proposed that convergence and interactions of these factors importantly influence CRC risk. We have previously hypothesized that genetic variation in the CHIEF (convergence of hormones, inflammation and energy-related factors) pathway would influence risk of CRC. In this paper, we utilize an Adaptive Rank Truncation Product (ARTP) statistical method to determine the overall pathway significance and then use that method to identify the key elements within the pathway associated with disease risk. Data from two population-based case-control studies of colon (n = 1555 cases and 1956 controls) and rectal (n = 754 cases and 959 controls) cancer were used. We use ARTP to estimate pathway and gene significance and polygenic scores based on ARTP findings to further estimate the risk associated with the pathway. Associations were further assessed based on tumor molecular phenotype. The CHIEF pathway was statistically significant for colon cancer (P(ARTP)= 0.03) with the most significant interferons (P(ARTP) = 0.0253), JAK/STAT/SOCS (P(ARTP) = 0.0111), telomere (P(ARTP) = 0.0399) and transforming growth factor β (P(ARTP) = 0.0043) being the most significant subpathways for colon cancer. For rectal cancer, interleukins (P(ARTP) = 0.0235) and selenoproteins (P ARTP = 0.0047) were statistically significant although the pathway overall was of borderline significance (P(ARTP) = 0.06). Interleukins (P(ARTP) = 0.0456) and mitogen-activated protein kinase (P(ARTP) = 0.0392) subpathways were uniquely significant for CpG island methylator phenotype-positive colon tumors. Increasing number of at-risk alleles was significantly associated with both colon [odds ratio (OR) = 6.21, 95% confidence interval (CI): 4.72, 8.16] and rectal (OR = 7.82, 95% CI: 5.26, 11.62) cancer. We conclude that elements of the CHIEF pathway are important for CRC risk.
炎症、激素和与能量相关的因素与结直肠癌(CRC)相关,并且已经提出这些因素的汇聚和相互作用重要地影响 CRC 风险。我们之前假设 CHIEF(激素、炎症和与能量相关的因素的汇聚)途径中的遗传变异会影响 CRC 的风险。在本文中,我们利用自适应秩截断乘积(ARTP)统计方法来确定整个途径的显著性,然后利用该方法确定与疾病风险相关的途径中的关键因素。使用来自两个基于人群的结肠癌(n = 1555 例病例和 1956 例对照)和直肠癌(n = 754 例病例和 959 例对照)病例对照研究的数据。我们使用 ARTP 来估计途径和基因的显著性,并基于 ARTP 结果的多基因评分进一步估计与途径相关的风险。基于肿瘤分子表型进一步评估关联。CHIEF 途径在结肠癌(P(ARTP)=0.03)中具有统计学意义,干扰素(P(ARTP)=0.0253)、JAK/STAT/SOCS(P(ARTP)=0.0111)、端粒(P(ARTP)=0.0399)和转化生长因子β(P(ARTP)=0.0043)是最显著的子途径。对于直肠癌,白细胞介素(P(ARTP)=0.0235)和硒蛋白(P ARTP = 0.0047)在统计学上是显著的,尽管该途径总体上具有边缘显著性(P(ARTP)=0.06)。白细胞介素(P(ARTP)=0.0456)和丝裂原活化蛋白激酶(P(ARTP)=0.0392)亚途径对 CpG 岛甲基化表型阳性结肠癌具有独特的意义。具有风险等位基因的数量增加与结肠癌(比值比(OR)=6.21,95%置信区间(CI):4.72,8.16)和直肠癌(OR=7.82,95%CI:5.26,11.62)显著相关。我们得出结论,CHIEF 途径的元素对 CRC 风险很重要。